168 related articles for article (PubMed ID: 28408701)
1. Mucoepidermoid Parotid Gland Tumor Found on Follow-up Radioiodine Scan for Differentiated Papillary Thyroid Cancer.
Naik C; Basu S
J Nucl Med Technol; 2017 Jun; 45(2):116-118. PubMed ID: 28408701
[TBL] [Abstract][Full Text] [Related]
2. Parotid gland involvement as an initial presentation of papillary thyroid carcinoma.
Kilic K; Sakat MS; Gozeler MS; Demirci E
Int J Oral Maxillofac Surg; 2017 Aug; 46(8):965-967. PubMed ID: 28442208
[TBL] [Abstract][Full Text] [Related]
3. Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association.
Saluja K; Butler RT; Pytynia KB; Zhao B; Karni RJ; Weber RS; El-Naggar AK
Hum Pathol; 2017 Oct; 68():189-192. PubMed ID: 28499545
[TBL] [Abstract][Full Text] [Related]
4. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
Malhotra G; Nair N; Awasare S; Baghel NS
Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
[No Abstract] [Full Text] [Related]
5. A case report of mucoepidermoid carcinoma of the parotid gland developing after radioiodine therapy for thyroid carcinoma.
Rodríguez-Cuevas S; Ocampo LB
Eur J Surg Oncol; 1995 Dec; 21(6):692. PubMed ID: 8631425
[TBL] [Abstract][Full Text] [Related]
6. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
Wu X; Gu H; Gao Y; Li B; Fan R
Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
[TBL] [Abstract][Full Text] [Related]
8. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment.
Soydal C; Araz M; Ozkan E; Arslantaş E; Kucuk ON; Aras G
Nucl Med Commun; 2015 Feb; 36(2):109-13. PubMed ID: 25321158
[TBL] [Abstract][Full Text] [Related]
9. Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.
Abhyankar A; Basu S
J Cancer Res Ther; 2015; 11(3):648. PubMed ID: 26458613
[TBL] [Abstract][Full Text] [Related]
10. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
11. [Mucoepidermoid carcinoma of the salivary glands after high dosage radiotherapy].
Henze M; Hittel JP
Laryngorhinootologie; 2001 May; 80(5):253-6. PubMed ID: 11417247
[TBL] [Abstract][Full Text] [Related]
12. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.
Bohuslavizki KH; Brenner W; Klutmann S; Hübner RH; Lassmann S; Feyerabend B; Lüttges J; Tinnemeyer S; Clausen M; Henze E
J Nucl Med; 1998 Jul; 39(7):1237-42. PubMed ID: 9669401
[TBL] [Abstract][Full Text] [Related]
13. Adrenal metastasis secondary to papillary thyroid carcinoma.
Koutkia P; Safer JD
Thyroid; 2001 Nov; 11(11):1077-9. PubMed ID: 11762719
[TBL] [Abstract][Full Text] [Related]
14. A patient with asymmetric parotid uptake on a diagnostic iodine-131 scan during thyroid cancer follow-up.
Frew J; Mallick U; Perros P
Thyroid; 2007 Aug; 17(8):801-2. PubMed ID: 17725441
[No Abstract] [Full Text] [Related]
15. Diagnostic 123I Whole Body Scan Prior to Ablation of Thyroid Remnant in Patients With Papillary Thyroid Cancer: Implications for Clinical Management.
Song H; Mosci C; Akatsu H; Basina M; Dosiou C; Iagaru A
Clin Nucl Med; 2018 Oct; 43(10):705-709. PubMed ID: 30153149
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan.
Kaya M; Cermik TF
Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510
[TBL] [Abstract][Full Text] [Related]
17. Solitary parotid metastasis from columnar cell carcinoma of the thyroid: a diagnostic dilemma.
Kini H; Pai RR; Kalpana S
Diagn Cytopathol; 2003 Feb; 28(2):72-5. PubMed ID: 12561024
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
Lungo M; Tenenbaum F; Chaumerliac P; Vons C; Mirat A; Beuzen F; Luton JP; Richard B
Ann Endocrinol (Paris); 2000 May; 61(2):147-50. PubMed ID: 10891665
[TBL] [Abstract][Full Text] [Related]
19. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
